Tumor Protein p73 anticorps (full length)
Aperçu rapide pour Tumor Protein p73 anticorps (full length) (ABIN7879267)
Antigène
Voir toutes Tumor Protein p73 (TP73) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- full length
-
Fonction
- p73 Antibody
-
Purification
- Protein G affinity chromatography
-
Immunogène
- A recombinant full-length human protein was used as the immunogen for this p73 antibody.
-
Isotype
- IgG2b, kappa
-
-
-
-
Indications d'application
- Optimal dilution of the p73 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store the p73 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- Tumor Protein p73 (TP73) (Tumor Protein P73 (TP73))
-
Autre désignation
- p73
-
Sujet
- The p53 gene is a widely studied anti-oncogene, or tumor suppressor gene. The p53 gene product can act as a negative regulator of cell growth in response to DNA damage. Mutations and allelic loss of the p53 gene have been associated with malignant transformation in a wide variety of human tumors. p53 shares considerable sequence similarity with p73, a gene that maps to a region in chromosome 1 that is frequently deleted in neuroblastomas. However, p73 does not appear to be activated by DNA damaging agents.
-
UniProt
- O15350
-
Pathways
- Regulation of Cell Size, Positive Regulation of Response to DNA Damage Stimulus
Antigène
-